Early Conversion from Tacrolimus to Belatacept in a Highly Sensitized Renal Allograft Recipient with Calcineurin Inhibitor-Induced de novo Post-Transplant Hemolytic Uremic Syndrome

BACKGROUND: Kidney transplantation is the first-line therapy for patients with end-stage renal disease since it offers greater long-term survival and improved quality of life when compared to dialysis. The advent of calcineurin inhibitor (CNI)-based maintenance immunosuppression has led to a clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatapudi, Vasishta S., Lonze, Bonnie E., Wu, Ming, Montgomery, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836164/
https://www.ncbi.nlm.nih.gov/pubmed/29594146
http://dx.doi.org/10.1159/000486158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836164/
https://www.ncbi.nlm.nih.gov/pubmed/29594146
http://dx.doi.org/10.1159/000486158

Ejemplares similares